Symbol="GLMD"
AssetType="Common Stock"
Name="Galmed Pharmaceuticals Ltd"
Description="Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company, focuses on the development of therapies for the treatment of liver diseases. The company is headquartered in Tel Aviv, Israel."
CIK="1595353"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="16 ZE'EV TYOMKIN ST. (4TH FL.), TEL AVIV, IL"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="4435800"
EBITDA="-13527000"
PERatio="None"
PEGRatio="0"
BookValue="7.14"
DividendPerShare="0"
DividendYield="0"
EPS="-7.92"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.377"
ReturnOnEquityTTM="-0.746"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-7.92"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="1"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="0.48"
EVToRevenue="-"
EVToEBITDA="0.51"
Beta="0.989"
num_52WeekHigh="14.18"
num_52WeekLow="2.52"
num_50DayMovingAverage="2.979"
num_200DayMovingAverage="1.087"
SharesOutstanding="1680200"
DividendDate="None"
ExDividendDate="None"
symbol="GLMD"
open="2.64"
high="2.77"
low="2.53"
price="2.65"
volume="48189.00"
latest_trading_day="2023-07-07"
previous_close="2.56"
change="0.09"
change_percent="3.5156%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="74"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="26"
Volume_recent_avg="155306"
Change_recent_avg="-0.03"
Delta_recent_avg="0.19"
Variance_recent_avg="0.1"
Change_ratio_recent_avg="-1.58"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="26"
Aroon_momentum_negative="74"
image_negative_thumbnail_id_1="1092"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0125.jpeg"
image_negative_thumbnail_id_2="1134"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0167.jpeg"
image_neutral_thumbnail_id_1="583"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0016.jpeg"
image_neutral_thumbnail_id_2="578"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0021.jpeg"
image_positive_thumbnail_id_1="969"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0131.jpeg"
image_positive_thumbnail_id_2="628"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0080.jpeg"
image_professor_thumbnail_id_1="1203"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0037.jpeg"
image_professor_thumbnail_id_2="1171"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0005.jpeg"
